BlackRock Institutional Trust’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$299K Sell
12,134
-2,126
-15% -$47.7K ﹤0.01% 3540
2016
Q3
$283K Sell
14,260
-1,516
-10% -$28.1K ﹤0.01% 3581
2016
Q2
$217K Hold
15,776
﹤0.01% 3627
2016
Q1
$217K Hold
15,776
﹤0.01% 3617
2015
Q4
$160K Hold
15,776
﹤0.01% 3687
2015
Q3
$159K Hold
15,776
﹤0.01% 3673
2015
Q2
$234K Sell
15,776
-1,246
-7% -$19.4K ﹤0.01% 3610
2015
Q1
$282K Hold
17,022
﹤0.01% 3600
2014
Q4
$258K Sell
17,022
-1,749
-9% -$25.4K ﹤0.01% 3610
2014
Q3
$266K Sell
18,771
-858
-4% -$12.2K ﹤0.01% 3575
2014
Q2
$278K Buy
19,629
+1,415
+8% +$21.5K ﹤0.01% 3658
2014
Q1
$312K Sell
18,214
-98
-0.5% -$1.63K ﹤0.01% 3649
2013
Q4
$269K Hold
18,312
﹤0.01% 3677
2013
Q3
$243K Sell
18,312
-763
-4% -$9.48K ﹤0.01% 3651
2013
Q2
$205K Buy
+19,075
New +$214K ﹤0.01% 3634

Other funds holding PMD

BlackRock Institutional Trust's PMD Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Psychemedics Corporation (PMD) stake by 15% in Q4 2016, selling an estimated $47.7K and leaving 12,134 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #3540.

BlackRock Institutional Trust first reported a position in PMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $312K in Q1 2014. 52 funds tracked by Wall St. Rank hold PMD as of Q4 2016.

  • BlackRock Institutional Trust held 12,134 shares of Psychemedics Corporation worth $299K as of Q4 2016.
  • BlackRock Institutional Trust sold 2,126 Psychemedics Corporation shares in Q4 2016, an estimated $47.7K.
  • Psychemedics Corporation made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3540 holding.
  • BlackRock Institutional Trust first reported a position in Psychemedics Corporation in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Psychemedics Corporation position peaked at $312K in Q1 2014.
  • 52 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.